Understanding and training in evidence-based medicine : a comprehensive survey from Colombian hematologists/oncologists (ONCOLGroup).

Entendimiento y entrenamiento en medicina basada en evidencia (MBE) : una encuesta estructurada a hematólogos y oncólogos de Colombia (ONCOLGroup).

Main Article Content

Henry Alberto Becerra
Andrés Felipe Cardona
Ludovic Reveiz
Arturo Martí Carvajal
Andrés Acevedo
Myriam Rodríguez
Diana Rivera
Hernán Carranza
Carlos Vargas
Jorge Miguel Otero
Juan Felipe Combariza
Claudia Casas
Leonardo Rojas
Alejandro Reyes
Mauricio Cuello
Óscar Arrieta
Abstract

Background: Approximately 10% of clinical trials published each year deal with cancer, however, only 20% of cancer interventions are supported by level I evidence. Objective: To describe the attitudes and opinions toward evidence-based medicine (EBM) practice in hematology and oncology in Colombia. Methods: In August of 2006 we surveyed a group of members from the Colombian Association of Hematology and Oncology (ACHO) on their attitudes and opinions toward EBM, their perceived understanding of EBM terminology, their familiarity with and use of sources of medical literature, as well as their EBM competence, based on their understanding of core concepts. The instrument designed to collect data was developed from existing yet not validated EBM survey instrument. Results: A total of 53 respondents completed the survey resulting in a response rate of 46% (considering the totality of members of the ACHO). There was widespread agreement that practicing EBM improves patient care (median score 8; range 4-10) and that every hematologist/oncologist should be familiar with critical appraisal techniques (median score 7; range, 4-9). The percentage of respondents who indicated that they understand and could explain to others the terms NNT, NNH, power and level of evidence was 60%, 22%, 75% and 75%, respectively. The NCCN guidelines (Clinical Practice Guidelines in Oncology/Hematology, National Comprehensive Cancer Network, US) were used regularly by 32% and at least once per month by 38% of respondents. 46% of participants were unaware of the PubMed search engine and 40% used it regularly, while 76% were unaware of the Cochrane Database of Systematic Reviews and only 24% had ever used it. The mean EBM competence score for all respondents was 73% (SD± 17%). Conclusions: The findings of this study confirm that hematologist/oncologist have a favorable attitude toward EBM in Colombia. Increased efforts to promote an understanding of EBM through workshops, publications and web based resources designed a cancer related audience seem to be indicated.

Keywords

Downloads

Download data is not yet available.

Article Details

Author Biographies (SEE)

Henry Alberto Becerra, Fundación Santa Fe de Bogotá ; Instituto de Oncología Carlos Ardila Lülle

Grupo Oncología Clínica y Traslacional, Instituto de Oncología Carlos Ardila Lülle, Fundación Santa Fe de Bogotá (Bogotá, Colombia).

Andrés Felipe Cardona, Fundación Santa Fe de Bogotá ; Instituto de Oncología Carlos Ardila Lülle

Grupo Oncología Clínica y Traslacional, Instituto de Oncología Carlos Ardila Lülle, Fundación Santa Fe de Bogotá (Bogotá, Colombia). Red Iberoamericana de la Colaboración Cochrane.

Ludovic Reveiz, Red Iberoamericana de la Colaboración Cochrane

Red Iberoamericana de la Colaboración Cochrane.

Arturo Martí Carvajal, Red Iberoamericana de la Colaboración Cochrane

Red Iberoamericana de la Colaboración Cochrane.

Andrés Acevedo, Fundación Santa Fe de Bogotá

Grupo Hematología y Trasplante de Médula Ósea, Fundación Santa Fe de Bogotá (Bogotá, Colombia).

Myriam Rodríguez, Fundación Santa Fe de Bogotá

Grupo Hematología y Trasplante de Médula Ósea, Fundación Santa Fe de Bogotá (Bogotá, Colombia).

Diana Rivera, Instituto Nacional de Cancerología ESE (INC)

Grupo Políticas y Movilización Social, Instituto Nacional de Cancerología ESE (INC) (Bogotá, Colombia).

Hernán Carranza, Fundación Santa Fe de Bogotá ; Instituto de Oncología Carlos Ardila Lülle

Grupo Oncología Clínica y Traslacional, Instituto de Oncología Carlos Ardila Lülle, Fundación Santa Fe de Bogotá (Bogotá, Colombia). Fundación para la Investigación Clínica y Molecular Aplicada del Cáncer (FICMAC); investigador asociado ONCOLGroup.

Carlos Vargas, Fundación Santa Fe de Bogotá ; Instituto de Oncología Carlos Ardila Lülle

Grupo Oncología Clínica y Traslacional, Instituto de Oncología Carlos Ardila Lülle, Fundación Santa Fe de Bogotá (Bogotá, Colombia). Fundación para la Investigación Clínica y Molecular Aplicada del Cáncer (FICMAC); investigador asociado ONCOLGroup.

Jorge Miguel Otero, Fundación Santa Fe de Bogotá ; Instituto de Oncología Carlos Ardila Lülle

Grupo Oncología Clínica y Traslacional, Instituto de Oncología Carlos Ardila Lülle, Fundación Santa Fe de Bogotá (Bogotá, Colombia). Fundación para la Investigación Clínica y Molecular Aplicada del Cáncer (FICMAC); investigador asociado ONCOLGroup.

Juan Felipe Combariza, Hospital Pablo Tobón Uribe

Grupo Hematología y Trasplante de Médula Ósea, Hospital Pablo Tobón Uribe (Medellín, Colombia).

Claudia Casas, Hospital Universitario San Ignacio

Grupo Hematología, Hospital Universitario San Ignacio (Bogotá, Colombia).

Leonardo Rojas, Instituto Nacional de Cancerología (INCAN)

Departamento de Oncología Clínica, Instituto Nacional de Cancerología (INCAN) (México D.F., México).

Alejandro Reyes, Hospital Santa Clara

Departamento de Medicina Interna, Hospital Santa Clara (Bogotá, Colombia).

Mauricio Cuello, Universidad de la República Oriental del Uruguay (UdelaR)

Hospital de Clínicas, Departamento Básico de Medicina/Facultad de Medicina - Universidad de la República Oriental del Uruguay (UdelaR) (Montevideo, Uruguay).

Óscar Arrieta, Instituto Nacional de Cancerología (INCAN)

Departamento de Oncología Clínica, Instituto Nacional de Cancerología (INCAN) (México D.F., México).

References

Greenwood M. The statistician and medical research. BMJ. 1948;2(4574):467.

González de Dios J. De la medicina basada en la evidencia a la evidencia basada en la medicina. An Pediatr (Barc). 2001;55(5):429-39.

Sackett DL, Rosenberg WM, Gray JA, Haynes RB, Richardson WS. Evidence based medicine: what it is and what it isn’t. BMJ. 1996;312(7023):71-2.

Sackett DL, Rosenberg WM, Haynes RB. Evidence-based medicine. How to practice and teach EBM. Edinburgh: Churchill Livingstone; 1997.

Guyatt GH, Meade MO, Jaeschke RZ, Cook DJ, RB. Practitioners of evidence based care. Not all clinicians need to appraise evidence from scratch but all need some skills. BMJ. 2000;320(7240):954-5.

Guyatt GH, editor. Users’ Guides to the Medical Literature: A Manual of Evidence-Based Clinical Practice. Chicago, IL: AMA Press; 2002.

Stacey D, Bennett CL, Barry MJ, Col NF, Eden KB, HolmesRovner M, et al. Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev. 2011;(10):CD001431.

Haynes RB, Devereaux PJ, Guyatt GH. Clinical expertise in the era of evidence-based medicine and patient choice. ACP J Club. 2002;136(2):A11-4.

DiMasi JA, Grabowski HG. Economics of new oncology drug development. J Clin Oncol. 2007;25(2):209-16. 10. Brooks AD, Sulimanoff I. Evidence-based oncology project. Surg Oncol Clin N Am. 2002;11(1):3-10, vii.

Brennan MF. Randomized clinical trials in oncology commentary. Surg Oncol Clin N Am. 2002;11(1):1-2, vii.

Cañedo R, Arencibia RJ, Perezleo L, Conill C, Araújo JA. La Colaboración Cochrane en Cuba: producción de ensayos clínicos en Iberoamérica. ACIMED. 2004;12(2).

Correa P, Fontham ET, Bravo JC, Bravo LE, Ruiz B, Zarama G, et al. Chemoprevention of gastric dysplasia: randomized trial of antioxidant supplements and anti-helicobacter pylori therapy. J Natl Cancer Inst. 2000;92(23):1881-8.

Gong C, Mera R, Bravo JC, Ruiz B, Diaz-Escamilla R, Fontham ET, et al. KRAS mutations predict progression of preneoplastic gastric lesions. Cancer Epidemiol Biomarkers Prev. 1999;8(2):167-71.

Buendia MT, Terselich G, Lozano JM, Viscaino MP. Acute lymphoblastic leukemia in children: nonrandomized comparison of conventional vs. intensive chemotherapy at the National Cancer Institute of Colombia. Med Pediatr Oncol. 1997;28(2):108-16.

Michaud G, McGowan JL, van der Jagt R, Wells G, Tugwell P. Are therapeutic decisions supported by evidence from health care research? Arch Intern Med. 1998;158(15):1665-8.

Ahmadi-Abhari S, Soltani A, Hosseinpanah F. Knowledge and attitudes of trainee physicians regarding evidence-based medicine: a questionnaire survey in Tehran, Iran. J Eval Clin Pract. 2008;14(5):775-9.

Novak K, Miric D, Jurin A, Vukojevic K, Aljinovic J, Caric A, et al. Awareness and use of evidence-based medicine databases and Cochrane Library among physicians in Croatia. Croat Med. J 2010;51(2):157-64.

Barghouti F, Halaseh L, Said T, Mousa AH, Dabdoub A. Evidence-based medicine among Jordanian family physicians: awareness, attitude, and knowledge. Can Fam Physician. 2009;55(7):e6-13.

Greenhalgh T. Narrative based medicine: narrative based medicine in an evidence based world. BMJ. 1999;318(7179):323-5.

Broom A, Adams J, Tovey P. Evidence-based healthcare in practice: a study of clinician resistance, professional de-skilling, and inter-specialty differentiation in oncology. Soc Sci Med. 2009;68(1):192-200.

Woodcock JD, Greenley S, Barton S. Doctors’ knowledge about evidence based medicine terminology. BMJ. 2002;324(7343):929-30.

Ulvenes LV, Aasland O, Nylenna M, Kristiansen IS. Norwegian physicians’ knowledge of and opinions about evidence-based medicine: cross-sectional study. PLoS One. 2009;4(11):e7828.

Al Omari M, Khader Y, Jadallah K, Dauod AS, Al-Shdifat AA. Awareness, attitude and practice of evidence-based medicine among primary health care doctors in Jordan. J Eval Clin Pract. 2009;15(6):1131-6.

Légaré F, Ratté S, Gravel K, Graham ID. Barriers and facilitators to implementing shared decision-making in clinical practice: update of a systematic review of health professionals’ perceptions. Patient Educ Couns. 2008;73(3):526-35.

Djulbegovic B, Loughran TP Jr, Hornung CA, Kloecker G, Efthimiadis EN, Hadley TJ, et al. The quality of medical evidence in hematology-oncology. Am J Med. 1999;106(2):198-205.

Galloway M, Baird G, Lennard A. Haematologists in district general hospitals practise evidence based medicine. Clin Lab Haematol. 1997;19(4):243-8.

Booth A. What proportion of healthcare is evidence based? Resource Guide. [Consultado el 18/abril/2006]. Disponible en: .

Pavlidis N, Hansen H, Stahel R. ESMO clinical recommendations: a practical guide for medical oncologists. Ann Oncol. 2007;18(11):1759-63.

Vigna-Taglianti F, Vineis P, Liberati A, Faggiano F. Quality of systematic reviews used in guidelines for oncology practice. Ann Oncol. 2006;17(4):691-701.

Dahm P, Poolman RW, Bhandari M, Fesperman SF, Baum J, Kosiak B, et al. Perceptions and competence in evidence-based medicine: a survey of the American Urological Association Membership. J Urol. 2009;181(2):767-77.

Jazieh AR, Azim HA, McClure J, Jahanzeb M. The process of NCCN guidelines adaptation to the Middle East and North Africa region. J Natl Compr Canc Netw. 2010;8 Suppl 3:S5-7.

Vincent S, Djulbegovic B. Oncology treatment recommendations can be supported only by 1-2% of high-quality published evidence. Cancer Treat Rev. 2005;31(4):319-22.

Satterlee WG, Eggers RG, Grimes DA. Effective medical education: insights from the Cochrane Library. Obstet Gynecol Surv. 2008;63(5):329-33.

OJS System - Metabiblioteca |